22-Gene Classifier May Help Guide Decision Making After Radical Prostatectomy

NEW YORK (Reuters Health) – The Decipher genomic classifier (GC) is a promising tool to help determine which men will benefit from hormone therapy in addition to salvage radiation after radical prostatectomy, researchers say. “These findings are the first solid pieces of evidence to lead to a practice change,” Dr. Phuoc Tran of Johns Hopkins […]

PET Predicts Response to Endocrine Therapy in ER+ Breast Cancer

Endocrine therapy is standard of care for estrogen-receptor positive (ER+) breast cancer, but only about half of women respond. At present, there is no method for identifying the women who are likely — and also unlikely — to respond. But a new approach looks to be useful: it involves a trial of estrogen and then […]